Ticker

6/recent/ticker-posts

Advertisement

Responsive Advertisement

China In Vitro Fertilization market will be US$ 2.8 Billion by 2025 - Renub Research

Global healthcare firms are the major IVF services firms in China. These firms have a "passive" company model, although they integrate relationships with tour agents and referral offices. Tapping into this increasing demand for IVF services in China has become a significant chance for overseas firms to explore fresh markets in medical care. China In Vitro Fertilization Market is projected to surpass USD 2.8 Billion by 2025.

In the last few years, the demand for Assisted Reproductive Techniques (ART) has grown many folds. The primary cause of the rise in ARTS is infertility among patients. ARTS is triggering due to fast lifestyle change, smoking, drinking, steroids, mental stress/trauma, and other medical conditions such as diabetes, cystic fibrosis, trauma, testicular failure, and Fallopian blockage of the tube, female ovarian dysfunction, etc. These variables, therefore, are supporting the China IVF market growth and development.

However, a major factor limiting the adoption of IVF treatment is the high cost of IVF procedures. Multiple births occur after 39 percent of IVF treatments, according to the Institute for Health Policy Studies at the University of California in the US, whereas in Europe they are 26 percent. However, the risk of birth after the procedure is relatively low. The IVF treatment success rate is only 28 percent to 35 percent, which declines with the woman's age. The success rate, for instance, was 32.2% for women under 35, 27.7% for women aged 35 to 37, 20.8% for women aged 38 to 39, 13.6% for women aged 40 to 42, 5% for women aged 43 to 44, and 1.9% for women aged over 44.



About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. 


Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)

Post a Comment

0 Comments